Joan edukira
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Hizkuntza
Eremu guztiak
Izenburua
Egilea
Gaia
Sailkapena
ISBN/ISSN
Etiketa
Bilatu
Aurreratua
High Prevalence of Advanced NA...
Erreferentzia bihurtu
SMS
Bidali
Imprimir
Erregistroa esportatu
Nora RefWorks
Nora EndNoteWeb
Nora EndNote
Permanent link
High Prevalence of Advanced NAFLD in Type 2 Diabetic Patients with Normal Liver Enzymes and Effect of Liraglutide on NAFLD: Meta-Analysis of the LEAD Program
Xehetasun bibliografikoak
Egile Nagusiak:
Armstrong, M
,
Falahati, A
,
Braun, O
,
Schmidt, W
,
Gough, S
,
Newsome, P
Formatua:
Conference item
Argitaratua:
2010
Aleari buruzko argibideak
Deskribapena
Antzeko izenburuak
MARC erregistroa
Antzeko izenburuak
High prevalence of advanced NAFLD in type 2 diabetic patients with unremarkable liver enzymes and effect of liraglutide on NAFLD: meta-analysis of the LEAD Program
nork: Armstrong, M, et al.
Argitaratua: (2010)
EFFECTS OF TWO YEARS OF LIRAGLUTIDE TREATMENT ON FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES: ANALYSIS OF THE LEAD-2 EXTENSION TRIAL
nork: Armstrong, M, et al.
Argitaratua: (2010)
Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program.
nork: Armstrong, M, et al.
Argitaratua: (2013)
Safety and efficacy of liraglutide in patients with type 2 diabetes with elevated liver enzymes: individual patient data meta-analysis of the LEAD programme
nork: Armstrong, M, et al.
Argitaratua: (2013)
Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: Individual patient data meta-analysis of the LEAD program
nork: Armstrong, M, et al.
Argitaratua: (2013)